Cornucopian Capital

We believe that the emergence of Medicine 3.0 – predicative, preventative, personalized, and participatory healthcare – presents an untapped opportunity to build companies focused on effectively delivering customized health outcomes in new and innovative ways. These companies – which we call Precision Health Brands™ – will combine new technologies and scientific insight to significantly improve patient-consumer engagement, building the foundation of a new, proactive paradigm for health: whenever possible, prevent disease rather than wait to cure it.